RPID Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. (RPID) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is a loss of $0.19 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -16.0% since its last earnings release on August 7, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables.
Sector
Healthcare
Industry
Medical Instruments/Supply